Enhance MD NAD+ prices
5 figures read September 2026.
Enhance MD publishes $169 a month for NAD+, charged on a calendar month, which is the only shape of figure this site treats as a monthly price.
What Enhance MD publishes
Enhance MD publishes a standing rate charged by the calendar month. Of the 46 sellers in this index that fall in the same bucket, that puts it with the 43% of the roster that publishes this shape of number rather than another one. That is the shape a buyer can act on directly, and 46 of 106 sellers here manage it.
The figure above is a standing rate, “MONTHLY PRICE”. This site never prints a price without that qualifier, on any surface, because the same number means a different thing depending on it — and in this corpus the same seller often prints several.
Every figure Enhance MD publishes — 5 figures, read September 2026
| Figure | What it is | Cycle, in their words | Route | Dose | Read |
|---|---|---|---|---|---|
| $84 | standing rate | “Billed every 48 weeks” | Oral | Not stated | September 2026 |
| $89 | standing rate | “Billed every 24 weeks” | Oral | Not stated | September 2026 |
| $94 | standing rate | “Billed every 12 weeks” | Oral | Not stated | September 2026 |
| $99 | standing rate | “Billed every 4 weeks” | Oral | Not stated | September 2026 |
| $169 | standing rate | “MONTHLY PRICE” | SubQ | Not stated | September 2026 |
In Enhance MD’s own words
- $84 standing rate
The page says: “12-month Save 15% Billed every 48 weeks $84/mo”
Route is ORAL/SUBLINGUAL NAD+ itself, not an NMN/NR precursor — the 'oral-precursor' enum value is used only because the rules provide no plain 'oral' value; molecule is NAD+. includesVerbatim says 'Vials' although this tab sells wafers.
Read from https://enhance.md/product/nad-therapy#wafers on September 2026.
- $89 standing rate
The page says: “6-month Save 10% Billed every 24 weeks $89/mo”
Oral/sublingual NAD+, not a precursor; see the $84 note on the enum.
Read from https://enhance.md/product/nad-therapy#wafers on September 2026.
- $94 standing rate
The page says: “3-month Save 5% Billed every 12 weeks $94/mo”
Oral/sublingual NAD+, not a precursor; see the $84 note on the enum.
Read from https://enhance.md/product/nad-therapy#wafers on September 2026.
- $99 standing rate
The page says: “1-month Billed every 4 weeks $99/mo”
Oral/sublingual NAD+, not a precursor; see the $84 note on the enum. Note the cycle is 4 weeks, not a calendar month.
Read from https://enhance.md/product/nad-therapy#wafers on September 2026.
- $169 standing rate
The page says: “MONTHLY PRICE $169 (Inj) / $84 (Wafers)”
The injectable price, published only inside the comparison table on this wafers page. The page says 'Injections' and never says subcutaneous or intramuscular; the enum has no unqualified 'injection' value. The '$84 (Wafers)' half of the same string is the 12-month wafer tier already recorded above.
Read from https://enhance.md/product/nad-therapy#wafers on September 2026.
Price disclosure score: 85 of 100
This scores what Enhance MD publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. Enhance MD sits 26 of 106.
| What is scored | What Enhance MD publishes | Points |
|---|---|---|
| An exact figure | The headline figure is an exact charge for a defined purchase, not a floor and not a first-period rate. | 30of 30 |
| A stated cadence | The seller states the interval it bills on, so a reader knows when the next charge lands. | 20of 20 |
| Visible on the page | Every headline figure (1 figure) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | None of this seller's 5 figures states a dose, so no cost per milligram can be worked out from the page. | 0of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 85of 100 |
What Enhance MD does not publish
Each of these is a count over what was actually read, not an impression. 5 figures were read from this seller, and every sentence below is measured against that number.
- No dose is stated beside any of the 5 figures, so nothing on the page divides into a cost per milligram.
Figures visible to a reader on the seller’s page
5 of 5
Figures stating a dose
0 of 5
Figures that resolve to a usable price
5 of 5
Source: Counted over the 5 figures read from Enhance MD’s own pages, September 2026. Each track is that figure count.
Where Enhance MD sits
63 other sellers in this index also state a Oral and SubQ route. Ranked with them on price disclosure, Enhance MD is 22 of 64. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.
Boards Enhance MD appears on
The reading record
This site has read Enhance MD once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.
Figures are read from Enhance MD’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.